logo
Select company
Select metric
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 578.67M0$ -146.58M
3/31/2025$ 125.09M0$ -150.98M
12/31/2024$ 208.52M0$ -155.86M
9/30/2024$ 496.26M0$ -133.14M
6/30/2024$ 423.66M0$ -153.21M
3/31/2024$ 572.63M0$ -132.89M
12/31/2023$ 264.84M0$ -124.27M
9/30/2023$ 169.26M0$ -113.38M
6/30/2023$ 2.75B5.99$ 459.64M
3/31/2023$ 1.85B0$ -89.23M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for PROKIDNEY CORP is calculated as follows: EV [ $ 314.93M ] / FCF [ $ 0 ]
(=) EV/FCF [ 0 ]

PROK - Enterprise Value over Free Cash Flow, Last 5 years

5.99

Minimum

Jun 30, 2023

5.99

Maximum

Jun 30, 2023

5.99

Average

5.99

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.47 with a standard deviation of 16.15.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max78.21
average23.47
median19.12
std16.15